<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02552732</url>
  </required_header>
  <id_info>
    <org_study_id>CIA138</org_study_id>
    <nct_id>NCT02552732</nct_id>
  </id_info>
  <brief_title>Nasal High Flow Therapy 30 Day Readmission Study</brief_title>
  <acronym>N3ADS</acronym>
  <official_title>Nasal High Flow (NHF) Therapy Use Following Hospitalization for an Exacerbation of COPD: A Feasibility Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fisher and Paykel Healthcare</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medical Research Institute of New Zealand</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Alana Healthcare</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Fisher and Paykel Healthcare</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this feasibility study is to provide data for a subsequent randomized controlled
      trial to investigate if patient outcomes will be improved after an acute COPD exacerbation
      using domiciliary nasal high flow therapy (NHF) compared to standard care. This feasibility
      study will investigate the following: process, resources, management and scientific aspects
      of delivering NHF as an adjunct therapy in COPD patients.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Study terminated due to change in business of US site.
  </why_stopped>
  <start_date>November 2015</start_date>
  <completion_date type="Actual">May 3, 2017</completion_date>
  <primary_completion_date type="Actual">May 3, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Device Feasibility</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>NHF Use for 30 Days Following Discharge After AECOPD</measure>
    <time_frame>30 days after hospital discharge</time_frame>
    <description>Use will be expressed as hours of myAIRVO 2 use per day over 30 days, as obtained by myAIRVO 2 electronic monitoring</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of Days of Use, Adjusted for Number of Days With myAIRVO 2 at Home</measure>
    <time_frame>30 days after hospital discharge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Average Use Per Day of the myAIRVO 2 During Week 1</measure>
    <time_frame>First week after hospital discharge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Average Use Per Day of the myAIRVO 2 During Week 2</measure>
    <time_frame>Second week after hospital discharge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Average Use Per Day of the myAIRVO 2 During Week 3</measure>
    <time_frame>Third week after hospital discharge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Average Use Per Day of the myAIRVO 2 During Week 4</measure>
    <time_frame>Fourth week after hospital discharge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Average Use Per Day on Days of myAIRVO 2 Use</measure>
    <time_frame>30 days after hospital discharge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Using Home Oxygen</measure>
    <time_frame>At study entry</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Who Reported Having Changed the myAIRVO 2 Flow Settings From the Initial Flow and the Corresponding Reduction in Flow</measure>
    <time_frame>30 days after hospital discharge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Who Where Screened But Were Excluded From Enrollment</measure>
    <time_frame>30 days after hospital discharge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Who Reported Having Changed the myAIRVO 2 Temperature Setting From the Initial Setting</measure>
    <time_frame>30 days after hospital discharge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Who Withdrew From Study After Enrollment, up to 30 Days</measure>
    <time_frame>At study completion</time_frame>
    <description>Number of participants who withdrew from study after enrollment, up to 30 days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With at Least One Hospital Readmission Within 30 Days of Discharge</measure>
    <time_frame>30 days after hospital discharge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reasons for Hospital Admissions</measure>
    <time_frame>30 days after hospital discharge</time_frame>
    <description>AECOPD, other respiratory cause or other cause</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>In Those That Had at Least One Hospital Readmission: Number of Readmissions</measure>
    <time_frame>30 days after hospital discharge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>In Those That Had at Least One Hospital Readmission: Time to First Hospital Readmission</measure>
    <time_frame>30 days after hospital discharge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>In Those That Had at Least One Hospital Readmission: Hospital Readmission Length</measure>
    <time_frame>30 days after hospital discharge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With at Least One ED Visit Within 30 Days of Discharge</measure>
    <time_frame>30 days after hospital discharge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reason for ED Visits</measure>
    <time_frame>30 days after hospital discharge</time_frame>
    <description>ED visit due to AECOPD</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With at Least One GP Visit Within 30 Days of Discharge</measure>
    <time_frame>30 days after hospital discharge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>LACE Index for Hospital Admissions</measure>
    <time_frame>30 days after hospital discharge</time_frame>
    <description>The LACE Index is a scoring tool for assessing the likelihood of readmission or death within 30 days of discharge. It is based of 4 parameters: length of stay (L), acuity of the admission (A), co-morbidities (C), number of Emergency Department visits within the last 6 months (E). Sub scores for each parameter are summed to give a LACE score ranging from 1 to 19. A score of 0 to 4 = Low; 5 to 9 = Moderate; and a score of ≥ 10 = High risk of readmission.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>FEV1 at Day 1 and 31</measure>
    <time_frame>1st and 31st day after hospital discharge</time_frame>
    <description>FEV1 change from day 1 to day 31</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SVC(in) at Day 1 and 31</measure>
    <time_frame>1st and 31st day after hospital discharge</time_frame>
    <description>Slow Vital Capacity (inspiratory) change from day 1 to day 31</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>FVC Change From Day 1 to Day 31</measure>
    <time_frame>1st and 31st day after hospital discharge</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">29</enrollment>
  <condition>Chronic Obstructive Pulmonary Disease</condition>
  <condition>COPD</condition>
  <arm_group>
    <arm_group_label>NHF with or without Oxygen</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>NHF with or without oxygen will be delivered to COPD patients using myAIRVO™ 2 for 30 days post hospital discharge</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>NHF with or without Oxygen</intervention_name>
    <description>NHF using myAIRVO™ 2 will be set at 25L/min at 37°C. However, all participants are able to lower the delivered temperature to 34°C.</description>
    <arm_group_label>NHF with or without Oxygen</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years of age or older

          -  Male and female

          -  Admitted to the respiratory ward(s) of either recruiting hospitals with AECOPD as the
             primary diagnostic reason for admission.

        Exclusion Criteria:

          -  Given a new home oxygen therapy prescription during the current hospital admission

          -  The investigator believes the participant or their care giver will be unable to safely
             use the myAIRVO 2 device following discharge

          -  They have any other condition which, at the investigator's discretion, is believed may
             present a safety risk or impact the feasibility of the study or the study results
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>James Fingleton, MBChB</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical Research Institute of New Zealand</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Alana HealthCare</name>
      <address>
        <city>Liverpool</city>
        <state>New York</state>
        <zip>13088</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Research Institute of New Zealand</name>
      <address>
        <city>Wellington</city>
        <zip>6242</zip>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>New Zealand</country>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>September 15, 2015</study_first_submitted>
  <study_first_submitted_qc>September 15, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 17, 2015</study_first_posted>
  <results_first_submitted>July 19, 2018</results_first_submitted>
  <results_first_submitted_qc>July 8, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">July 24, 2020</results_first_posted>
  <last_update_submitted>July 8, 2020</last_update_submitted>
  <last_update_submitted_qc>July 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>November 20, 2015</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/32/NCT02552732/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>NHF With or Without Oxygen</title>
          <description>Patients with or without an existing Oxygen prescription will receive NHF using myAIRVO™ 2.
NHF with supplemental Oxygen will be given to participants with an oxygen prescription using myAIRVO™ 2: NHF will be set at 25L/min at 37°C. However, all participants are able to lower the delivered temperature to 34°C.
NHF without supplemental Oxygen will be given to participants who do not have an oxygen prescription using myAIRVO™ 2: NHF will be set at 25L/min at 37°C. However, all participants are able to lower the delivered temperature to 34°C.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="29"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Day 1 SpO2 &gt; 96%</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>NHF With or Without Oxygen</title>
          <description>NHF with or without oxygen will be delivered to COPD patients using myAIRVO™ 2 for 30 days post hospital discharge
NHF with or without Oxygen: NHF using myAIRVO™ 2 will be set at 25L/min at 37°C. However, all participants are able to lower the delivered temperature to 34°C.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="29"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="67.34" spread="10.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>NZ European</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Maori</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>New Zealand</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>NHF Use for 30 Days Following Discharge After AECOPD</title>
        <description>Use will be expressed as hours of myAIRVO 2 use per day over 30 days, as obtained by myAIRVO 2 electronic monitoring</description>
        <time_frame>30 days after hospital discharge</time_frame>
        <population>NHF use for 30 days following discharge after AECOPD. Use will be expressed as hours of myAIRVO 2 use per day over 30 days, as obtained by myAIRVO 2 electronic monitoring.</population>
        <group_list>
          <group group_id="O1">
            <title>NHF With or Without Oxygen</title>
            <description>Patients with or without an existing Oxygen prescription will receive NHF using myAIRVO™ 2.
NHF with supplemental Oxygen will be given to participants with an oxygen prescription using myAIRVO™ 2: NHF will be set at 25L/min at 37°C. However, all participants are able to lower the delivered temperature to 34°C.
NHF without supplemental Oxygen will be given to participants who do not have an oxygen prescription using myAIRVO™ 2: NHF will be set at 25L/min at 37°C. However, all participants are able to lower the delivered temperature to 34°C.</description>
          </group>
        </group_list>
        <measure>
          <title>NHF Use for 30 Days Following Discharge After AECOPD</title>
          <description>Use will be expressed as hours of myAIRVO 2 use per day over 30 days, as obtained by myAIRVO 2 electronic monitoring</description>
          <population>NHF use for 30 days following discharge after AECOPD. Use will be expressed as hours of myAIRVO 2 use per day over 30 days, as obtained by myAIRVO 2 electronic monitoring.</population>
          <units>hours per day</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.6560" spread="2.4137"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Days of Use, Adjusted for Number of Days With myAIRVO 2 at Home</title>
        <time_frame>30 days after hospital discharge</time_frame>
        <group_list>
          <group group_id="O1">
            <title>NHF With or Without Oxygen</title>
            <description>NHF with or without oxygen will be delivered to COPD patients using myAIRVO™ 2 for 30 days post hospital discharge
NHF with or without Oxygen: NHF using myAIRVO™ 2 will be set at 25L/min at 37°C. However, all participants are able to lower the delivered temperature to 34°C.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Days of Use, Adjusted for Number of Days With myAIRVO 2 at Home</title>
          <units>percentage of days of use</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="57.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Average Use Per Day of the myAIRVO 2 During Week 1</title>
        <time_frame>First week after hospital discharge</time_frame>
        <group_list>
          <group group_id="O1">
            <title>NHF With or Without Oxygen</title>
            <description>NHF with or without oxygen will be delivered to COPD patients using myAIRVO™ 2 for 30 days post hospital discharge
NHF with or without Oxygen: NHF using myAIRVO™ 2 will be set at 25L/min at 37°C. However, all participants are able to lower the delivered temperature to 34°C.</description>
          </group>
        </group_list>
        <measure>
          <title>Average Use Per Day of the myAIRVO 2 During Week 1</title>
          <units>hours per day</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.0319" spread="3.7065"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Average Use Per Day of the myAIRVO 2 During Week 2</title>
        <time_frame>Second week after hospital discharge</time_frame>
        <group_list>
          <group group_id="O1">
            <title>NHF With or Without Oxygen</title>
            <description>NHF with or without oxygen will be delivered to COPD patients using myAIRVO™ 2 for 30 days post hospital discharge
NHF with or without Oxygen: NHF using myAIRVO™ 2 will be set at 25L/min at 37°C. However, all participants are able to lower the delivered temperature to 34°C.</description>
          </group>
        </group_list>
        <measure>
          <title>Average Use Per Day of the myAIRVO 2 During Week 2</title>
          <units>hours per day</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.7715" spread="2.236"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Average Use Per Day of the myAIRVO 2 During Week 3</title>
        <time_frame>Third week after hospital discharge</time_frame>
        <group_list>
          <group group_id="O1">
            <title>NHF With or Without Oxygen</title>
            <description>NHF with or without oxygen will be delivered to COPD patients using myAIRVO™ 2 for 30 days post hospital discharge
NHF with or without Oxygen: NHF using myAIRVO™ 2 will be set at 25L/min at 37°C. However, all participants are able to lower the delivered temperature to 34°C.</description>
          </group>
        </group_list>
        <measure>
          <title>Average Use Per Day of the myAIRVO 2 During Week 3</title>
          <units>hours per day</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.0447" spread="2.4633"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Average Use Per Day of the myAIRVO 2 During Week 4</title>
        <time_frame>Fourth week after hospital discharge</time_frame>
        <group_list>
          <group group_id="O1">
            <title>NHF With or Without Oxygen</title>
            <description>NHF with or without oxygen will be delivered to COPD patients using myAIRVO™ 2 for 30 days post hospital discharge
NHF with or without Oxygen: NHF using myAIRVO™ 2 will be set at 25L/min at 37°C. However, all participants are able to lower the delivered temperature to 34°C.</description>
          </group>
        </group_list>
        <measure>
          <title>Average Use Per Day of the myAIRVO 2 During Week 4</title>
          <units>hours per day</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.22" spread="2.69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Average Use Per Day on Days of myAIRVO 2 Use</title>
        <time_frame>30 days after hospital discharge</time_frame>
        <group_list>
          <group group_id="O1">
            <title>NHF With or Without Oxygen</title>
            <description>NHF with or without oxygen will be delivered to COPD patients using myAIRVO™ 2 for 30 days post hospital discharge
NHF with or without Oxygen: NHF using myAIRVO™ 2 will be set at 25L/min at 37°C. However, all participants are able to lower the delivered temperature to 34°C.</description>
          </group>
        </group_list>
        <measure>
          <title>Average Use Per Day on Days of myAIRVO 2 Use</title>
          <units>hours per day on days of myAIRVO 2 use</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.4326" spread="3.4917"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Using Home Oxygen</title>
        <time_frame>At study entry</time_frame>
        <group_list>
          <group group_id="O1">
            <title>NHF With or Without Oxygen</title>
            <description>Patients with or without an existing Oxygen prescription will receive NHF using myAIRVO™ 2.
NHF with supplemental Oxygen will be given to participants with an oxygen prescription using myAIRVO™ 2: NHF will be set at 25L/min at 37°C. However, all participants are able to lower the delivered temperature to 34°C.
NHF without supplemental Oxygen will be given to participants who do not have an oxygen prescription using myAIRVO™ 2: NHF will be set at 25L/min at 37°C. However, all participants are able to lower the delivered temperature to 34°C.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Using Home Oxygen</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="29"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Who Reported Having Changed the myAIRVO 2 Flow Settings From the Initial Flow and the Corresponding Reduction in Flow</title>
        <time_frame>30 days after hospital discharge</time_frame>
        <group_list>
          <group group_id="O1">
            <title>NHF With or Without Oxygen</title>
            <description>NHF with or without oxygen will be delivered to COPD patients using myAIRVO™ 2 for 30 days post hospital discharge
NHF with or without Oxygen: NHF using myAIRVO™ 2 will be set at 25L/min at 37°C. However, all participants are able to lower the delivered temperature to 34°C.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Who Reported Having Changed the myAIRVO 2 Flow Settings From the Initial Flow and the Corresponding Reduction in Flow</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Who Where Screened But Were Excluded From Enrollment</title>
        <time_frame>30 days after hospital discharge</time_frame>
        <group_list>
          <group group_id="O1">
            <title>NHF With or Without Oxygen</title>
            <description>Patients with or without an existing Oxygen prescription will receive NHF using myAIRVO™ 2.
NHF with supplemental Oxygen will be given to participants with an oxygen prescription using myAIRVO™ 2: NHF will be set at 25L/min at 37°C. However, all participants are able to lower the delivered temperature to 34°C.
NHF without supplemental Oxygen will be given to participants who do not have an oxygen prescription using myAIRVO™ 2: NHF will be set at 25L/min at 37°C. However, all participants are able to lower the delivered temperature to 34°C.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Who Where Screened But Were Excluded From Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="29"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Who Reported Having Changed the myAIRVO 2 Temperature Setting From the Initial Setting</title>
        <time_frame>30 days after hospital discharge</time_frame>
        <group_list>
          <group group_id="O1">
            <title>NHF With or Without Oxygen</title>
            <description>NHF with or without oxygen will be delivered to COPD patients using myAIRVO™ 2 for 30 days post hospital discharge
NHF with or without Oxygen: NHF using myAIRVO™ 2 will be set at 25L/min at 37°C. However, all participants are able to lower the delivered temperature to 34°C.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Who Reported Having Changed the myAIRVO 2 Temperature Setting From the Initial Setting</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Who Withdrew From Study After Enrollment, up to 30 Days</title>
        <description>Number of participants who withdrew from study after enrollment, up to 30 days</description>
        <time_frame>At study completion</time_frame>
        <group_list>
          <group group_id="O1">
            <title>NHF With or Without Oxygen</title>
            <description>NHF with or without oxygen will be delivered to COPD patients using myAIRVO™ 2 for 30 days post hospital discharge
NHF with or without Oxygen: NHF using myAIRVO™ 2 will be set at 25L/min at 37°C. However, all participants are able to lower the delivered temperature to 34°C.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Who Withdrew From Study After Enrollment, up to 30 Days</title>
          <description>Number of participants who withdrew from study after enrollment, up to 30 days</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="29"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With at Least One Hospital Readmission Within 30 Days of Discharge</title>
        <time_frame>30 days after hospital discharge</time_frame>
        <group_list>
          <group group_id="O1">
            <title>NHF With or Without Oxygen</title>
            <description>NHF with or without oxygen will be delivered to COPD patients using myAIRVO™ 2 for 30 days post hospital discharge
NHF with or without Oxygen: NHF using myAIRVO™ 2 will be set at 25L/min at 37°C. However, all participants are able to lower the delivered temperature to 34°C.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With at Least One Hospital Readmission Within 30 Days of Discharge</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Reasons for Hospital Admissions</title>
        <description>AECOPD, other respiratory cause or other cause</description>
        <time_frame>30 days after hospital discharge</time_frame>
        <group_list>
          <group group_id="O1">
            <title>NHF With or Without Oxygen</title>
            <description>NHF with or without oxygen will be delivered to COPD patients using myAIRVO™ 2 for 30 days post hospital discharge
NHF with or without Oxygen: NHF using myAIRVO™ 2 will be set at 25L/min at 37°C. However, all participants are able to lower the delivered temperature to 34°C.</description>
          </group>
        </group_list>
        <measure>
          <title>Reasons for Hospital Admissions</title>
          <description>AECOPD, other respiratory cause or other cause</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>AECOPD</title>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Other Respiratory</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Non-respiratory</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>In Those That Had at Least One Hospital Readmission: Number of Readmissions</title>
        <time_frame>30 days after hospital discharge</time_frame>
        <group_list>
          <group group_id="O1">
            <title>NHF With or Without Oxygen</title>
            <description>NHF with or without oxygen will be delivered to COPD patients using myAIRVO™ 2 for 30 days post hospital discharge
NHF with or without Oxygen: NHF using myAIRVO™ 2 will be set at 25L/min at 37°C. However, all participants are able to lower the delivered temperature to 34°C.</description>
          </group>
        </group_list>
        <measure>
          <title>In Those That Had at Least One Hospital Readmission: Number of Readmissions</title>
          <units>readmission/participant</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>In Those That Had at Least One Hospital Readmission: Time to First Hospital Readmission</title>
        <time_frame>30 days after hospital discharge</time_frame>
        <group_list>
          <group group_id="O1">
            <title>NHF With or Without Oxygen</title>
            <description>NHF with or without oxygen will be delivered to COPD patients using myAIRVO™ 2 for 30 days post hospital discharge
NHF with or without Oxygen: NHF using myAIRVO™ 2 will be set at 25L/min at 37°C. However, all participants are able to lower the delivered temperature to 34°C.</description>
          </group>
        </group_list>
        <measure>
          <title>In Those That Had at Least One Hospital Readmission: Time to First Hospital Readmission</title>
          <units>days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26" spread="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>In Those That Had at Least One Hospital Readmission: Hospital Readmission Length</title>
        <time_frame>30 days after hospital discharge</time_frame>
        <group_list>
          <group group_id="O1">
            <title>NHF With or Without Oxygen</title>
            <description>NHF with or without oxygen will be delivered to COPD patients using myAIRVO™ 2 for 30 days post hospital discharge
NHF with or without Oxygen: NHF using myAIRVO™ 2 will be set at 25L/min at 37°C. However, all participants are able to lower the delivered temperature to 34°C.</description>
          </group>
        </group_list>
        <measure>
          <title>In Those That Had at Least One Hospital Readmission: Hospital Readmission Length</title>
          <units>days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" spread="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With at Least One ED Visit Within 30 Days of Discharge</title>
        <time_frame>30 days after hospital discharge</time_frame>
        <group_list>
          <group group_id="O1">
            <title>NHF With or Without Oxygen</title>
            <description>NHF with or without oxygen will be delivered to COPD patients using myAIRVO™ 2 for 30 days post hospital discharge
NHF with or without Oxygen: NHF using myAIRVO™ 2 will be set at 25L/min at 37°C. However, all participants are able to lower the delivered temperature to 34°C.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With at Least One ED Visit Within 30 Days of Discharge</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="29"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Reason for ED Visits</title>
        <description>ED visit due to AECOPD</description>
        <time_frame>30 days after hospital discharge</time_frame>
        <group_list>
          <group group_id="O1">
            <title>NHF With or Without Oxygen</title>
            <description>NHF with or without oxygen will be delivered to COPD patients using myAIRVO™ 2 for 30 days post hospital discharge
NHF with or without Oxygen: NHF using myAIRVO™ 2 will be set at 25L/min at 37°C. However, all participants are able to lower the delivered temperature to 34°C.</description>
          </group>
        </group_list>
        <measure>
          <title>Reason for ED Visits</title>
          <description>ED visit due to AECOPD</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With at Least One GP Visit Within 30 Days of Discharge</title>
        <time_frame>30 days after hospital discharge</time_frame>
        <group_list>
          <group group_id="O1">
            <title>NHF With or Without Oxygen</title>
            <description>NHF with or without oxygen will be delivered to COPD patients using myAIRVO™ 2 for 30 days post hospital discharge
NHF with or without Oxygen: NHF using myAIRVO™ 2 will be set at 25L/min at 37°C. However, all participants are able to lower the delivered temperature to 34°C.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With at Least One GP Visit Within 30 Days of Discharge</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="29"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>LACE Index for Hospital Admissions</title>
        <description>The LACE Index is a scoring tool for assessing the likelihood of readmission or death within 30 days of discharge. It is based of 4 parameters: length of stay (L), acuity of the admission (A), co-morbidities (C), number of Emergency Department visits within the last 6 months (E). Sub scores for each parameter are summed to give a LACE score ranging from 1 to 19. A score of 0 to 4 = Low; 5 to 9 = Moderate; and a score of ≥ 10 = High risk of readmission.</description>
        <time_frame>30 days after hospital discharge</time_frame>
        <group_list>
          <group group_id="O1">
            <title>NHF With or Without Oxygen</title>
            <description>NHF with or without oxygen will be delivered to COPD patients using myAIRVO™ 2 for 30 days post hospital discharge
NHF with or without Oxygen: NHF using myAIRVO™ 2 will be set at 25L/min at 37°C. However, all participants are able to lower the delivered temperature to 34°C.</description>
          </group>
        </group_list>
        <measure>
          <title>LACE Index for Hospital Admissions</title>
          <description>The LACE Index is a scoring tool for assessing the likelihood of readmission or death within 30 days of discharge. It is based of 4 parameters: length of stay (L), acuity of the admission (A), co-morbidities (C), number of Emergency Department visits within the last 6 months (E). Sub scores for each parameter are summed to give a LACE score ranging from 1 to 19. A score of 0 to 4 = Low; 5 to 9 = Moderate; and a score of ≥ 10 = High risk of readmission.</description>
          <units>scores on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="29"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.069" spread="1.4188"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>FEV1 at Day 1 and 31</title>
        <description>FEV1 change from day 1 to day 31</description>
        <time_frame>1st and 31st day after hospital discharge</time_frame>
        <group_list>
          <group group_id="O1">
            <title>NHF With or Without Oxygen</title>
            <description>NHF with or without oxygen will be delivered to COPD patients using myAIRVO™ 2 for 30 days post hospital discharge
NHF with or without Oxygen: NHF using myAIRVO™ 2 will be set at 25L/min at 37°C. However, all participants are able to lower the delivered temperature to 34°C.</description>
          </group>
        </group_list>
        <measure>
          <title>FEV1 at Day 1 and 31</title>
          <description>FEV1 change from day 1 to day 31</description>
          <units>litres per min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0042" spread="0.1973"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>SVC(in) at Day 1 and 31</title>
        <description>Slow Vital Capacity (inspiratory) change from day 1 to day 31</description>
        <time_frame>1st and 31st day after hospital discharge</time_frame>
        <group_list>
          <group group_id="O1">
            <title>NHF With or Without Oxygen</title>
            <description>NHF with or without oxygen will be delivered to COPD patients using myAIRVO™ 2 for 30 days post hospital discharge
NHF with or without Oxygen: NHF using myAIRVO™ 2 will be set at 25L/min at 37°C. However, all participants are able to lower the delivered temperature to 34°C.</description>
          </group>
        </group_list>
        <measure>
          <title>SVC(in) at Day 1 and 31</title>
          <description>Slow Vital Capacity (inspiratory) change from day 1 to day 31</description>
          <units>litres per min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0027" spread="0.393"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>FVC Change From Day 1 to Day 31</title>
        <time_frame>1st and 31st day after hospital discharge</time_frame>
        <group_list>
          <group group_id="O1">
            <title>NHF With or Without Oxygen</title>
            <description>NHF with or without oxygen will be delivered to COPD patients using myAIRVO™ 2 for 30 days post hospital discharge
NHF with or without Oxygen: NHF using myAIRVO™ 2 will be set at 25L/min at 37°C. However, all participants are able to lower the delivered temperature to 34°C.</description>
          </group>
        </group_list>
        <measure>
          <title>FVC Change From Day 1 to Day 31</title>
          <units>litres per min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.075" spread="0.3306"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Over 31 days (1 month)</time_frame>
      <group_list>
        <group group_id="E1">
          <title>NHF With or Without Oxygen</title>
          <description>NHF with or without oxygen will be delivered to COPD patients using myAIRVO™ 2 for 30 days post hospital discharge
NHF with or without Oxygen: NHF using myAIRVO™ 2 will be set at 25L/min at 37°C. However, all participants are able to lower the delivered temperature to 34°C.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="29"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="29"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="29"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>General unwellness/tired</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="29"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="29"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Oral thrush</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="29"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="29"/>
              </event>
              <event>
                <sub_title>AECOPD</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="29"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Early termination leading to small numbers of subjects analyzed</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr Stanislav Tatkov</name_or_title>
      <organization>Fisher and Paykel Healthcare</organization>
      <phone>09 5740100</phone>
      <email>stanislav.tatkov@fphcare.co.nz</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

